U.S. FDA delays panel meeting on Perrigo's OTC birth control pill

In the NewsArticle

Oct 26

Reuters shared the FDA’s announcement to postpone its advisory committee meeting to review HRA Pharma’s application for an over-the-counter birth control pill.

FDAOTC accessUnited States

Free the Pill

U.S. FDA delays panel meeting on Perrigo's OTC birth control pill

Removing the ​‘prescription’ barrier

FDA postpones meeting to review over-the-counter birth control pills

Removing the ‘prescription’ barrier